Ontogeny shapes the ability of ETV6::RUNX1 to enhance hematopoietic stem cell self-renewal and disrupt early lymphopoiesis

Mohamed Eldeeb; Anna Konturek-Ciesla; Qinyu Zhang; Shabnam Kharazi; Johanna Tingvall-Gustafsson; Jonas Ungerbäck; Mikael Sigvardsson; David Bryder

doi:10.1038/s41375-024-02149-2

Ontogeny shapes the ability of ETV6::RUNX1 to enhance hematopoietic stem cell self-renewal and disrupt early lymphopoiesis

Mohamed Eldeeb, Anna Konturek-Ciesla, Qinyu Zhang, Shabnam Kharazi, Johanna Tingvall-Gustafsson, Jonas Ungerbäck, Mikael Sigvardsson, David Bryder

Linköping University

Forskningsoutput: Tidskriftsbidrag › Letter › Peer review

Originalspråk	engelska
Sidor (från-till)	455-459
Antal sidor	5
Tidskrift	Leukemia
Volym	38
Nummer	2
Tidigt onlinedatum	2024
DOI	https://doi.org/10.1038/s41375-024-02149-2
Status	Published - 2024

Ämnesklassifikation (UKÄ)

Hematologi

Tillgång till dokument

10.1038/s41375-024-02149-2Licens: CC BY

Citera det här

@article{eb1247ae99f14956a92c148139692b13,

title = "Ontogeny shapes the ability of ETV6::RUNX1 to enhance hematopoietic stem cell self-renewal and disrupt early lymphopoiesis",

author = "Mohamed Eldeeb and Anna Konturek-Ciesla and Qinyu Zhang and Shabnam Kharazi and Johanna Tingvall-Gustafsson and Jonas Ungerb{\"a}ck and Mikael Sigvardsson and David Bryder",

year = "2024",

doi = "10.1038/s41375-024-02149-2",

language = "English",

volume = "38",

pages = "455--459",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "2",

}

TY - JOUR

T1 - Ontogeny shapes the ability of ETV6::RUNX1 to enhance hematopoietic stem cell self-renewal and disrupt early lymphopoiesis

AU - Eldeeb, Mohamed

AU - Konturek-Ciesla, Anna

AU - Zhang, Qinyu

AU - Kharazi, Shabnam

AU - Tingvall-Gustafsson, Johanna

AU - Ungerbäck, Jonas

AU - Sigvardsson, Mikael

AU - Bryder, David

PY - 2024

Y1 - 2024

U2 - 10.1038/s41375-024-02149-2

DO - 10.1038/s41375-024-02149-2

M3 - Letter

C2 - 38243088

AN - SCOPUS:85182661083

SN - 0887-6924

VL - 38

SP - 455

EP - 459

JO - Leukemia

JF - Leukemia

IS - 2

ER -